(0.04%) 5 208.50 points
(0.10%) 39 036 points
(-0.10%) 18 177 points
(0.38%) $78.78
(-2.00%) $2.15
(-0.33%) $2 323.50
(-0.47%) $27.48
(-0.21%) $962.85
(0.11%) $0.929
(0.27%) $10.85
(0.20%) $0.798
(-0.42%) $90.97
-50.00% ¥ 2.00
Live Chart Being Loaded With Signals
tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer...
Stats | |
---|---|
Volumen de hoy | 12.99M |
Volumen promedio | 0 |
Capitalización de mercado | 0.00 |
Last Dividend | ¥0.800 ( 2012-12-26 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | -0.0564 |
ATR14 | ¥0 (0.00%) |
tella, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
tella, Inc. Finanzas
Annual | 2021 |
Ingresos: | ¥106.41M |
Beneficio Bruto: | ¥-98.59M (-92.65 %) |
EPS: | ¥-9.04 |
FY | 2021 |
Ingresos: | ¥106.41M |
Beneficio Bruto: | ¥-98.59M (-92.65 %) |
EPS: | ¥-9.04 |
FY | 2020 |
Ingresos: | ¥76.36M |
Beneficio Bruto: | ¥-37.44M (-49.02 %) |
EPS: | ¥-45.26 |
FY | 2019 |
Ingresos: | ¥202.18M |
Beneficio Bruto: | ¥44.81M (22.16 %) |
EPS: | ¥-53.81 |
Financial Reports:
No articles found.
tella, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
First Dividend | ¥0.600 | 2010-12-28 |
Last Dividend | ¥0.800 | 2012-12-26 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | ¥1.400 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.22 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8306.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7702.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6859.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6235.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
4956.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4114.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3333.T | Ex Dividend Junior | 2024-02-19 | Annually | 0 | 0.00% | |
2412.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9325.T | Ex Dividend Junior | 2023-09-28 | Sporadic | 0 | 0.00% | |
8052.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -8.92 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -2.91 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.442 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.18 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.043 | 0.800 | 8.57 | 6.85 | [0.8 - 2.5] |
cashRatioTTM | 1.043 | 1.500 | 5.31 | 7.97 | [0.2 - 2] |
debtRatioTTM | 0.00805 | -1.500 | 9.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -6 403.73 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -5.05 | [0 - 30] |
freeCashFlowPerShareTTM | -7.57 | 2.00 | -3.79 | -7.57 | [0 - 20] |
debtEquityRatioTTM | 0.0132 | -1.500 | 9.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | -0.927 | 1.000 | -10.00 | -10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -7.46 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -309.84 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.326 | 0.800 | -1.160 | -0.928 | [0.5 - 2] |
Total Score | -4.17 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.227 | 1.000 | -0.124 | 0 | [1 - 100] |
returnOnEquityTTM | -1.442 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -7.57 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -5.05 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00699 | 1.500 | -3.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -7.65 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -3.51 |
tella, Inc.
tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer. It is also involved in the provision of consultation services on the establishment and maintenance of cell processing centers, and on introduction of management systems for cell cultivation; and lease of standard operating procedure and regular checks on manufacturing operation management and training of cell cultivation technicians. In addition, the company provides consultation services on training of expertise regarding treatment practice; and support services for the assessment of therapies, documentation required for treatment practice, and cognition and information providing activities for physicians and patients. tella, Inc. was founded in 2004 and is based in Tokyo, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico